Myofibroma: all 344 studies
Page 4 of 4. Open to participants first (41), then studies with results posted, then the rest; newest registration first within each.
- The Benefits and Limits of Laparoscopic Surgery for Uterine FibroidsStatus unknownNCT00860002
- Fertility After Uterine Artery Embolisation for the Treatment of LeiomyomasCompletedNCT00839722Phase 2
- Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 in Japanese Postmenopausal WomenCompletedNCT00826436
- Clinical Trial of Uterine Artery Embolization for Uterine LeiomyomaStatus unknownNCT00821275Phase 2/3
- A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.CompletedNCT00776074Phase 2
- Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation StudyWithdrawnNCT00768742Not applicable
- Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine FibroidsCompletedNCT00746031Phase 4
- Randomized Controlled Trial (RCT)Comparing GYNAECARE MORCELLEX Versus ROTOCUT GI Tissue MorcellatorsCompletedNCT00743080Phase 4
- Mifepristone for Treatment of Uterine FibroidsCompletedNCT00712595Phase 2/3
- Establishment of Fibroid Tissue BankTerminatedNCT00710346
- Radiofrequency Ablation of Uterine FibroidsTerminatedNCT00584207Early Phase 1
- The Effect of Mifepristone on Uterine Fibroids and Breast TissueCompletedNCT00579475Phase 1
- Far Infrared Radiation Treatment for Uterine FibroidsStatus unknownNCT00574418Phase 1
- Study Evaluating PRA-027 Multiple Ascending Doses In Cycling And Postmenopausal WomenCompletedNCT00543790Phase 1
- Uterine Artery Occlusion for Fibroid Related BleedingTerminatedNCT00496067Not applicable
- Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese FemalesCompletedNCT00444704Phase 1
- Questionnaire Study to Assess Quality of Life After Treatment of FibroidsStatus unknownNCT00390494
- Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic AgentCompletedNCT00361036Phase 1
- Uterine Artery Embolization for Symptomatic FibroidsCompletedNCT00354471
- Postpartum Uterine RegressionCompletedNCT00341848
- Fibroid Growth StudyCompletedNCT00340288
- Risk Factors for Uterine Fibroids: A Case Control StudyCompletedNCT00339547
- Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)CompletedNCT00332033Phase 2
- Tissue Bank of Biological Specimens From Patients With Gynecologic DiseaseStatus unknownNCT00299481
- MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 ValidationCompletedNCT00295217Phase 3
- Laparoscopic Occlusion of Uterine Vessels Compared to Uterine Fibroid Embolization for Treatment of Uterine FibroidsStatus unknownNCT00277680Not applicable
- Uterine Fibroid Pregnancy RegistryTerminatedNCT00232713
- A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine LeiomyomasTerminatedNCT00219778Phase 2
- Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the FutureWithdrawnNCT00180739Phase 4
- MR Guided Focused Ultrasound Surgery in the Treatment of Uterine FibroidsCompletedNCT00166270Not applicable
- Post-Operative Pain Management in Patients Undergoing Uterine Artery Embolisation for Symptomatic LeiomyomataStatus unknownNCT00163930
- A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine FibroidsCompletedNCT00160459Phase 2
- A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine FibroidsCompletedNCT00160381Phase 3
- Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large FibroidsCompletedNCT00159328Phase 4
- Safety of Treatment of Uterine Fibroids With AsoprisnilCompletedNCT00156208Phase 3
- Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine FibroidsCompletedNCT00156195Phase 3
- A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.CompletedNCT00156182Phase 2
- Study of Asoprisnil in the Treatment of Uterine Fibroids.CompletedNCT00156156Phase 3
- Health-Related QoL Among Women Receiving Hysterectomy in NTUHStatus unknownNCT00155870
- Treatment of Uterine Fibroids With Asoprisnil(J867)CompletedNCT00152269Phase 3
- A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine FibroidsCompletedNCT00152256Phase 3
- A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a HysterectomyCompletedNCT00150644Phase 2
- Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine FibroidsCompletedNCT00100191Phase 3
- Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor AntagonistCompletedNCT00044876Phase 2